Substance use disorder is characterized by repeated use of a substance, leading to
clinically significant distress, making it a serious public health concern. The …

Currently, there are no approved pharmacotherapies for addiction to cocaine and other
psychostimulant drugs. Several studies have proposed that cannabidiol (CBD) could be a …

Background Polydrug use may challenge effective treatment for substance use disorders.
We evaluate whether secondary substance use modifies the association between treatment …

ABSTRACT Background and Aims Cocaine use disorder (CUD) is a significant public health
concern for which no efficacious pharmacological interventions are available. Cannabidiol …

Background No effective pharmacotherapies exist for the treatment of crack cocaine use
disorders. Emerging data suggests that cannabinoids may play a role in reducing cocaine …

Background Cannabinoids may have an important therapeutic potential for the treatment of
dependence on crack cocaine. Cannabidiol (CBD), in particular, has anxiolytic …

Rationale Cocaine addiction is a global health problem with no approved
pharmacotherapies. Preclinical research indicates the non-intoxicating phytocannabinoid …

Violence is a major adverse outcome associated with cocaine use. Brazil presents a unique
case study with high levels of cocaine use. We present a systematized, comprehensive …

Since 24 states and the District of Columbia have legalized marijuana in some form,
suppliers of legal marijuana have developed Cannabis sativa products for use in electronic …

Cocaine use is a public health concern in many countries worldwide, particularly in the
Americas and Oceania. Overdose deaths involving stimulants, such as cocaine, have been …